• linkedin
  • Increase Font
  • Sharebar

    New Products: Neuromodulation system for OAB targets tibial nerve



    Neuromodulation system for overactive bladder targets tibial nerve

    Dublin—Medtronic PLC has launched the NURO System, which delivers percutaneous tibial neuromodulation (PTNM) for the treatment of overactive bladder (OAB). The NURO system delivers a mild electrical pulse to the tibial nerve via a small needle that is placed in the skin near the ankle and is attached to a neurostimulator. By using neuromodulation, PTNM targets the tibial nerve and indirectly activates the central nervous system to help alleviate symptoms of OAB. The therapy is administered in physician offices during weekly 30-minute sessions over a 12-week period. Side effects associated with the NURO System include temporary mild pain or skin inflammation near the stimulation site.  

    For more information, visit www.medtronic.com.

    Ben Schwartz
    Ben Schwartz is Associate Editor, Contemporary OB/GYN.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available